Hungary Drug Report 2017

Country Drug Report 2017

About this report

This report presents the top-level overview of the drug phenomenon in Hungary, covering drug supply, use and public health problems as well as drug policy and responses. The statistical data reported relate to 2015 (or most recent year) and are provided to the EMCDDA by the national focal point, unless stated otherwise.

At a glance

NBData presented here are either national estimates (prevalence of use, opioid drug users) or reported numbers through the EMCDDA indicators (treatment clients, syringes, deaths and HIV diagnosis, drug law offences and seizures). Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.


National drug strategy and coordination

What are the long-term aims of drug policy in Hungary? How are these aims to be achieved? How is drug policy coordinated at national level?

Learn more
Public expenditure

Understanding the costs of drug-related actions is an important aspect of policy evaluation.

Learn more
Drug laws and drug law offences

What substances and activities does Hungary control under its drug laws? What are the penalties for offences? How are new psychoactive substances controlled?

Learn more
Drug use

How many people in Hungary have ever used drugs? What drugs have they used? How many have used drugs recently? How many are using drugs in highly risky ways?

Learn more
Drug harms

What are the main infectious diseases linked to drug injecting in Hungary? How many died of drug overdose in the last year? How many drug-related medical emergencies occurred?

Learn more

What part does prevention play in Hungary drug strategy. What are the main prevention approaches used in the country and who do they target?

Learn more
Harm reduction

How does the Hungary measure in terms of provision of needle and syringe programmes, peer naloxone programmes, supervised drug consumption rooms and heroin-assisted treatment.

Learn more

How is the drug treatment system organised in Hungary? How is it financed? How is the provision of treatment divided between inpatient and outpatient settings?

Learn more
Drug use and responses in prison

Which authorities are responsible for prison health in Hungary? What forms of drug treatment and harm reduction are provided in prisons, and how widely?

Learn more
Quality assurance

What is done in Hungary to ensure that the prevention and treatment interventions used are effective and provide a good return on public expenditure?

Learn more
Drug-related research

In which areas of study is drug-related research carried out in Hungary? How is this research funded? Are any types of research emphasised in the national drug strategy?

Learn more
Drug markets

What is known about drug supply and trafficking in the Hungary? How pure or strong are the drugs available? What do they cost? What are the main aims of supply reduction efforts?

Learn more
Key statistics

Key drug statistics for Hungary

Learn more
EU dashboard

Focus on Hungary

Learn more


Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.